These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 28974891)

  • 1. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
    Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
    Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status.
    Koumbi L; Pollicino T; Raimondo G; Stampoulis D; Khakoo S; Karayiannis P
    Virus Res; 2016 Jul; 220():150-60. PubMed ID: 27132039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome remodeling related to hepatitis B virus replication in HepG2 cells.
    Gong Q; Chen S; Guo J; Sun H; Zheng G; Liu Q; Ren H; He S
    DNA Cell Biol; 2011 Jun; 30(6):347-54. PubMed ID: 21345131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome.
    Chong CK; Cheng CYS; Tsoi SYJ; Huang FY; Liu F; Seto WK; Lai CL; Yuen MF; Wong DK
    Antiviral Res; 2017 Aug; 144():1-7. PubMed ID: 28499864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells.
    Luo L; Chen S; Gong Q; Luo N; Lei Y; Guo J; He S
    Int J Mol Med; 2013 Jan; 31(1):197-204. PubMed ID: 23128981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
    He W; Li LX; Liao QJ; Liu CL; Chen XL
    World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription.
    Yuan Y; Zhao K; Yao Y; Liu C; Chen Y; Li J; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Wu C; Chen X
    Antiviral Res; 2019 Dec; 172():104619. PubMed ID: 31600533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
    Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
    World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
    J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells.
    Xin XM; Li GQ; Jin YY; Zhuang M; Li D
    World J Gastroenterol; 2008 Jun; 14(24):3849-54. PubMed ID: 18609708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIRF, a Novel Ubiquitin Ligase, Inhibits Hepatitis B Virus Replication Through Effect on HBV Core Protein and H3 Histones.
    Qian G; Hu B; Zhou D; Xuan Y; Bai L; Duan C
    DNA Cell Biol; 2015 May; 34(5):327-32. PubMed ID: 25664994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome.
    Yang G; Feng J; Liu Y; Zhao M; Yuan Y; Yuan H; Yun H; Sun M; Bu Y; Liu L; Liu Z; Niu JQ; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(24):7345-7358. PubMed ID: 31695772
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.